Author Details

Остроумова, О. Д

Issue Section Title File
No 14 (2012) Articles Arterial'naya gipertenziya i kognitivnye narusheniya: vozmozhnosti korrektsii
No 14 (2012) Articles Variabel'nost' arterial'nogo davleniya -novaya mishen' dlya profilaktiki insul'ta
No 13 (2013) Articles Vliyanie amlodipina na kognitivnye funktsii u pozhilykh bol'nykh arterial'noy gipertoniey
No 6 (2014) Articles Dislipidemiya u patsienta s arterial'noy gipertenziey: kombinirovannaya terapiya gipolipidemicheskimi i antigipertenzivnymi lekarstvennymi sredstvami
No 18 (2014) Articles Vozmozhnosti korrektsii dislipidemii u patsientov s arterial'noy gipertenziey
No 9 (2017) Articles ALGORITHM OF THE SELECTION OF ANTIHYPERTENSIVE THERAPY AGAINST THE INVOLVEMENT OF HEART AS A TARGET ORGAN IN ARTERIAL HYPERTENSION
No 15 (2017) Articles Possibilities of amlodipine/lisinopril fixed-dose combination in real clinical practice
No 15 (2017) Articles Cerebroprotective effects of fixed-dose combination of perindopril arginine/ indapamide
Vol 26, No 4 (2019) Articles Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Vol 26, No 9 (2019) Articles Drug-induced pirouette-type tachycardia
Vol 26, No 9 (2019) Articles Drug-induced nightmares
Vol 26, No 14 (2019) Articles Hypoglycemic drugs and drug-induced heart failure
Vol 26, No 14 (2019) Articles Drug-induced hyperthyroidism
Vol 27, No 2 (2020) Articles Medicines associated with the development of drug-induced constipation
Vol 27, No 4 (2020) Articles Individual drugs associated with overweight inducing
Vol 27, No 4 (2020) Articles Medicines associated with the development of osteoporosis
Vol 27, No 3 (2020) Articles Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
Vol 27, No 3 (2020) Articles Drug-induced hypothyroidism
Vol 27, No 3 (2020) Articles The benefits of fixed combinations for the treatment of arterial hypertension in women with menopausal disorders: focus on Gipotef
Vol 27, No 5 (2020) Articles Drug-induced diseases: epidemiology and urgency of the problem
Vol 27, No 6 (2020) Articles Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance
Vol 27, No 13 (2020) Articles The role of the disturbances in the intestinal barrier structure in relation to cardiovascular diseases pathogenesis and rebamipid potential in their correction
Vol 27, No 13 (2020) Articles Drug-induced liver injury with cholestasis. Part 1: focus on drugs for the treatment of cardiovascular diseases and hypoglycemic drugs
Vol 27, No 14 (2020) Articles Drug-induced liver injury with cholestasis. Part 2: focus on antidiabetic drugs
Vol 28, No 2 (2021) Articles Drug-induced autoimmune hepatitis
Vol 28, No 3 (2021) Articles Drug-induced atrial fibrillation/flutter associated with drugs affecting the central nervous system
Vol 28, No 3 (2021) Articles The relationship of cardiovascular disease with increased intestinal permeability: results from scientific and controlled clinical trials. Focus on the potential of rebamipide
Vol 28, No 3 (2021) Articles The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Vol 28, No 5 (2021) Articles Tobacco smoking as a risk factor for the development of drug-induced diseases
Vol 28, No 10 (2021) Articles Potential clinically significant drug interactions of drugs with green tea
Vol 28, No 11 (2021) Articles Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors
Vol 28, No 11 (2021) Articles Medication errors as risk factor for drug-induced diseases
Vol 29, No 6 (2022) Articles Drug-induced kidney stone disease
Vol 29, No 6 (2022) Articles Drugs, the use of which is associated with the development of drug-induced kidney stone disease. Part 1

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies